GlassScriptPhysician profile
Michael Crimi
NPI 1265474357
$28,422.47
in general payments reported to CMS, 2019-2025
29 companies · $5,759 in 2025
The $5,759 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,832 · 2022: $5,809 · 2023: $5,515 · 2024: $5,506 · 2025: $5,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $2,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $14,400.00 |
| Food and Beverage | $2,380.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $24,000.00 | 2021-2025 | Venacure 1470 Pro |
| Abbvie INC. | $1,593.44 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $623.48 | 2022-2025 | Breztri, Airsupra |
| Amarin Pharma, INC. | $265.61 | 2021-2023 | |
| Amgen INC. | $243.44 | 2021-2025 | Krystexxa, Otezla, Repatha |
| Lilly USA, LLC | $227.68 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Medtronic, INC. | $203.39 | 2021-2023 | Synchromedii |
| Nevro Corp. | $190.04 | 2022 | |
| Stryker Corporation | $173.89 | 2024 | Mako |
| Esperion Therapeutics, INC. | $124.98 | 2022 | |
| Pfizer INC. | $108.49 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.10 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.40 | 2025 | Lifevest |
| Teva Pharmaceuticals USA, INC. | $85.32 | 2023-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Exact Sciences Corporation | $62.66 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $48.07 | 2024-2025 | |
| Axsome Therapeutics, INC. | $40.34 | 2025 | Auvelity |
| Dexcom, INC. | $31.85 | 2023-2024 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $26.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.10 | 2021 | |
| Corium, LLC | $21.09 | 2023 | Azstarys |
| Cipher Pharmaceuticals US LLC | $19.41 | 2025 | Spinosad, Natroba |
| Supernus Pharmaceuticals, INC. | $18.77 | 2021 | |
| Hologic Sales and Service, LLC | $18.55 | 2023 | Thinprep 2000 Processor, Aptima |
| Harmony Biosciences LLC | $18.00 | 2024 | |
| Novo Nordisk INC | $15.93 | 2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.07 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.20 | 2021 | |
| Ironshore Pharmaceuticals INC. | $12.78 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Crimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.